King Louis XIII Strain — Effects, THC, UK

King Louis XIII Strain Guide: Effects, THC Content & UK Medical Cannabis

The King Louis XIII strain, often abbreviated as “King Louis” or “KL13,” is a premium cannabis cultivar renowned for its potent effects and luxurious profile. This comprehensive guide explores everything UK cannabis consumers and patients need to know about the king louis strain, from its genetic origins to its therapeutic potential under the UK’s medical cannabis framework.

King Louis XIII Genetics and Lineage

King Louis XIII is an indica-dominant hybrid resulting from the crossing of two legendary strains: OG Kush and LA Confidential. This genetic combination creates a strain that inherits the best characteristics of both parent varieties.

OG Kush, a West Coast staple, contributes robust potency and complex flavour profiles, whilst LA Confidential, a pure indica, adds dense bud structure and profound relaxation effects. The resulting king louis strain exhibits a predominantly indica phenotype (approximately 80% indica, 20% sativa), making it particularly suitable for evening consumption and therapeutic applications.

The strain’s name references the French royal family, reflecting its premium positioning within the cannabis market. Its reputation for quality has made it a sought-after cultivar among UK medical cannabis patients and connoisseurs alike.

THC and CBD Content

King Louis XIII is classified as a high-THC strain, making it unsuitable for novice users but ideal for those seeking potent effects. Here’s what you need to know about its cannabinoid profile:

• THC Content: Typically ranges from 18% to 25%, with premium phenotypes reaching up to 27%
• CBD Content: Generally less than 0.1%, making this a THC-dominant strain
• CBN Content: Trace amounts, typically under 0.5%

The high THC concentration combined with minimal CBD means King Louis XIII produces pronounced psychoactive effects. This cannabinoid ratio makes the strain particularly relevant for UK medical cannabis patients experiencing conditions where higher THC concentrations are therapeutically beneficial, subject to appropriate medical supervision and prescription.

Effects of King Louis XIII

Users of the king louis strain typically report a rapid onset of effects, with noticeable impacts within 10-20 minutes of consumption. The effects profile is distinctly indica-dominant:

• Deep physical relaxation and muscle tension relief
• Strong sedative properties conducive to sleep
• Euphoric mood elevation and mental clarity initially
• Gradual transition to couch-lock and profound body heaviness
• Enhanced sensory perception and appetite stimulation
• Potential for anxiolytic (anxiety-reducing) effects at moderate doses
• Increased introspection and mental calm
• Extended duration, typically lasting 3-4 hours

The strain’s potency means careful dosing is essential. First-time users should start with minimal quantities, as the combination of high THC and strong indica effects can induce overwhelming sedation. UK patients accessing King Louis XIII through the medical cannabis framework should follow their consultant’s dosage recommendations precisely.

Terpene Profile

The king louis strain’s distinctive character derives significantly from its terpene composition. Primary terpenes include:

• Myrcene: The dominant terpene, contributing earthy, herbal notes and enhancing sedative properties
• Caryophyllene: Provides spicy, peppery undertones and potential anti-inflammatory benefits
• Limonene: Adds subtle citrus elements and mood-elevating properties
• Linalool: Contributes floral notes and anxiolytic effects
• Pinene: Minor constituent offering pine-like aromatics

This terpene profile works synergistically with the cannabinoid content, creating what cannabis researchers term the “entourage effect.” The combination explains why King Louis XIII produces such distinctive, well-rounded effects compared to single-cannabinoid preparations.

Flavour and Aroma

The king louis strain delivers a complex sensory experience that justifies its premium positioning:

Aroma: King Louis XIII presents a pungent, multi-layered aroma dominated by earthy, herbal notes with underlying sweetness. Users frequently detect hints of sandalwood, cedar, and subtle fruit undertones. The overall profile is sophisticated and distinctive, often intensifying when buds are handled or ground.

Flavour: Consumption reveals a smooth, complex taste experience. Initial notes are typically spicy and peppery, transitioning to sweet, earthy undertones with woody characteristics. Some phenotypes exhibit subtle citrus or pine finishes. The smoke is generally smooth, though the potency may cause throat irritation for sensitive users.

Medicinal Uses and Therapeutic Potential

King Louis XIII’s powerful effects profile positions it as potentially beneficial for various medical conditions under UK medical cannabis prescribing frameworks:

• Chronic Pain Management: The potent analgesic effects and muscle-relaxing properties make it suitable for patients with persistent pain conditions
• Insomnia and Sleep Disorders: Strong sedative effects can help patients achieve deeper, more sustained sleep
• Anxiety and PTSD: At appropriate doses, the anxiolytic properties may benefit anxiety-related conditions
• Muscle Spasticity: Particularly relevant for patients with multiple sclerosis or other spasticity-related conditions
• Loss of Appetite: The munchies-inducing properties may benefit patients undergoing chemotherapy or managing cachexia
• Nausea: Potential anti-nausea properties may assist cancer patients or those with gastrointestinal conditions

Medical applications should always occur under appropriate healthcare supervision and prescription.

King Louis XIII and UK Medical Cannabis Availability

The UK’s medical cannabis regulatory framework, introduced in 2018, permits specialist consultants to prescribe cannabis-based medicinal products to patients where conventional treatments have proven ineffective. King Louis XIII, as a specific strain, may not be directly prescribed but rather cannabis products with comparable cannabinoid and terpene profiles may be recommended.

UK patients can access medical cannabis through:

• Specialist NHS consultants (limited availability)
• Private best UK cannabis clinics operating under UK regulatory guidelines
• Licensed cannabis-based medicinal products approved by the MHRA

Patients should note that whilst high-THC strains like King Louis XIII demonstrate potential therapeutic value, access requires documented medical conditions and evidence that conventional treatments are inadequate. Prescription requires specialist medical oversight.

Conclusion

The King Louis XIII strain represents a premium cannabis cultivar with profound effects, complex terpene profiles, and considerable therapeutic potential. Its high THC content, combined with strong indica characteristics, makes the king louis strain particularly suitable for experienced users and medical patients seeking powerful symptom relief. For UK patients considering medical cannabis, consultation with qualified specialists can determine whether King Louis XIII or comparable strains align with their treatment requirements.